BRCA2 and breast cancer: Remarkably, minigenes of the splicing vector pSAD have been successfully used to assay more than 300 variants of the breast cancer gene BRCA2 (Acedo et al., 2015; Fraile-Bethencourt et al., 2017, 2019b).